Literature DB >> 11348633

A K(ATP) channel opener inhibited myocardial reperfusion action potential shortening and arrhythmias.

A J Workman1, I MacKenzie, B J Northover.   

Abstract

Low concentrations of certain K(ATP) channel openers have been reported to exert a moderate inhibitory effect on arrhythmias during post-ischaemic early myocardial reperfusion, but the accompanying effects on the time course of changes in action potentials in intact hearts have not yet been studied. We report that in rat isolated hearts, reperfusion following 10 min of regional no-flow ischaemia was associated with both an acute, marked, but transient, shortening of ventricular repolarisation (by 63%) during reperfusion, and a high incidence (90%) of ventricular tachyarrhythmias. The K(ATP) channel opener Ro 31-6930 [2-(6-cyano-2,2-dimethyl-2H-1-benzopyran-4-yl)-pyridine 1-oxide], delivered prior to ischaemia at a relatively low concentration (0.5 microM), significantly reduced the incidence and duration of reperfusion arrhythmias, and prevented the associated acute action potential shortening during reperfusion, each in a glibenclamide (1 microM)-sensitive manner (P<0.05, n=10-15 hearts). This was associated with a moderate and non-arrhythmogenic action potential shortening during ischaemia (a potentially "cardioprotective" effect). However, these data highlight the potential harm these drugs may cause, since a higher concentration of Ro 31-6930 caused marked shortening of action potentials and significant pro-arrhythmia during ischaemia.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11348633     DOI: 10.1016/s0014-2999(01)00972-4

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  5 in total

1.  Do hypoxemia or hypercapnia predispose to atrial fibrillation in breathing disorders, and, if so, how?

Authors:  Antony J Workman; Andrew C Rankin
Journal:  Heart Rhythm       Date:  2010-04-08       Impact factor: 6.343

Review 2.  Electrophysiological mechanisms of long and short QT syndromes.

Authors:  Gary Tse; Yin Wah Fiona Chan; Wendy Keung; Bryan P Yan
Journal:  Int J Cardiol Heart Vasc       Date:  2016-11-26

3.  Modeling Short QT Syndrome Using Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes.

Authors:  Ibrahim El-Battrawy; Huan Lan; Lukas Cyganek; Zhihan Zhao; Xin Li; Fanis Buljubasic; Siegfried Lang; Gökhan Yücel; Katherine Sattler; Wolfram-Hubertus Zimmermann; Jochen Utikal; Thomas Wieland; Ursula Ravens; Martin Borggrefe; Xiao-Bo Zhou; Ibrahim Akin
Journal:  J Am Heart Assoc       Date:  2018-03-24       Impact factor: 5.501

4.  Long-Term Follow-Up of Patients With Short QT Syndrome: Clinical Profile and Outcome.

Authors:  Ibrahim El-Battrawy; Johanna Besler; Volker Liebe; Rainer Schimpf; Erol Tülümen; Boris Rudic; Siegfried Lang; Christian Wolpert; Xiaobo Zhou; Ibrahim Akin; Martin Borggrefe
Journal:  J Am Heart Assoc       Date:  2018-12-04       Impact factor: 5.501

5.  Ischemic Postconditioning Reduces Reperfusion Arrhythmias by Adenosine Receptors and Protein Kinase C Activation but Is Independent of KATP Channels or Connexin 43.

Authors:  Emiliano Raúl Diez; Jose Antonio Sánchez; Natalia Jorgelina Prado; Amira Zulma Ponce Zumino; David García-Dorado; Roberto Miguel Miatello; Antonio Rodríguez-Sinovas
Journal:  Int J Mol Sci       Date:  2019-11-25       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.